Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative delirium after deep hypothermic cardiopulmonary bypass
ChiCTR2100054365Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in traumatic brain injury (TBI) and postoperative delirium (POD) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Incidence of postoperative in-hospital delirium. Started Dec 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
traumatic brain injury (TBI)postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100054365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054365.